0001209191-17-031418.txt : 20170510
0001209191-17-031418.hdr.sgml : 20170510
20170510195540
ACCESSION NUMBER: 0001209191-17-031418
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170510
FILED AS OF DATE: 20170510
DATE AS OF CHANGE: 20170510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1217
BUSINESS ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-697-3939
MAIL ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenberg Robert J.
CENTRAL INDEX KEY: 0001625594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 17832032
MAIL ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-10
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001625594
Greenberg Robert J.
849 MITTEN ROAD, SUITE 104
BURLINGAME
CA
94010
1
0
0
0
Common Stock
2017-05-10
4
M
0
25000
2.67
A
25000
D
Common Stock
2017-05-10
4
S
0
22180
21.03
D
2820
D
Common Stock
2017-05-10
4
S
0
2820
21.867
D
0
D
Stock Option (right to buy)
2.67
2017-05-10
4
M
0
25000
0.00
D
2020-06-01
Common Stock
25000
50655
D
This is the weighted average purchase price of the shares, which ranged from $20.62 to $21.57 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $21.77 to $21.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
The shares subject to the option will vest in equal quarterly installments over a three year period that commenced on June 1, 2015 and will end on Marcn 1, 2018, subject to the Reporting Person's continued service through each vesting date.
/s/ Brian Dow, as Attorney-in-Fact
2017-05-10